1. Home
  2. BLTE vs LMAT Comparison

BLTE vs LMAT Comparison

Compare BLTE & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLTE
  • LMAT
  • Stock Information
  • Founded
  • BLTE 2018
  • LMAT 1983
  • Country
  • BLTE United States
  • LMAT United States
  • Employees
  • BLTE N/A
  • LMAT N/A
  • Industry
  • BLTE Biotechnology: Pharmaceutical Preparations
  • LMAT Medical/Dental Instruments
  • Sector
  • BLTE Health Care
  • LMAT Health Care
  • Exchange
  • BLTE Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • BLTE 1.9B
  • LMAT 1.9B
  • IPO Year
  • BLTE 2022
  • LMAT 2006
  • Fundamental
  • Price
  • BLTE $61.10
  • LMAT $80.26
  • Analyst Decision
  • BLTE Strong Buy
  • LMAT Buy
  • Analyst Count
  • BLTE 4
  • LMAT 7
  • Target Price
  • BLTE $96.67
  • LMAT $100.67
  • AVG Volume (30 Days)
  • BLTE 29.7K
  • LMAT 187.8K
  • Earning Date
  • BLTE 05-14-2025
  • LMAT 05-01-2025
  • Dividend Yield
  • BLTE N/A
  • LMAT 0.99%
  • EPS Growth
  • BLTE N/A
  • LMAT 30.45
  • EPS
  • BLTE N/A
  • LMAT 1.97
  • Revenue
  • BLTE N/A
  • LMAT $226,256,000.00
  • Revenue This Year
  • BLTE N/A
  • LMAT $11.00
  • Revenue Next Year
  • BLTE N/A
  • LMAT $8.48
  • P/E Ratio
  • BLTE N/A
  • LMAT $40.86
  • Revenue Growth
  • BLTE N/A
  • LMAT 13.19
  • 52 Week Low
  • BLTE $40.00
  • LMAT $71.42
  • 52 Week High
  • BLTE $86.53
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • BLTE 51.45
  • LMAT 39.99
  • Support Level
  • BLTE $59.04
  • LMAT $78.01
  • Resistance Level
  • BLTE $62.55
  • LMAT $83.51
  • Average True Range (ATR)
  • BLTE 2.51
  • LMAT 3.21
  • MACD
  • BLTE 0.32
  • LMAT -0.88
  • Stochastic Oscillator
  • BLTE 74.06
  • LMAT 14.87

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: